First PrEP In China: Gilead Faces Changing Market For Truvada
Generics Loom For Treatment Use
The China approval of Gilead’s Truvada in a new indication brings up a familiar question: how soon will domestic generics take over a new market with large potential amid a fast-changing environment?
You may also be interested in...
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
China releases technical requirements for foreign drug makers to register their chemical drugs in the country, and issues patent linkage details, which a legal expert says needs to be closely examined.